SETTLEMENT AGREEMENTSettlement Agreement • November 9th, 2021
Contract Type FiledNovember 9th, 2021This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice (the “United States”); kaléo, Inc. (“kaléo” or “Kaléo”); and Rebecca Socol (the “Relator”), through their authorized representatives (together, the “Parties”).
ContractSettlement Agreement • November 5th, 2021
Contract Type FiledNovember 5th, 2021SETTLEMENT AGREEMENT This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice (the “United States”); kaléo, Inc. (“kaléo” or “Kaléo”); and Rebecca Socol (the “Relator”), through their authorized representatives (together, the “Parties”). RECITALS A. Kaléo is a Virginia corporation with headquarters in Richmond, Virginia. Kaléo is a pharmaceutical manufacturer. B. From October 2016 to September 2020, Kaléo manufactured and marketed Evzio, the brand name for its injectable form of naloxone hydrocholoride. Evzio was one of several commercially available naloxone products indicated for use on an emergent basis in the case of opioid overdose. During the relevant period, Evzio was the highest-priced version of naloxone on the market, and insurers frequently required the submission of prior authorization requests before they would approve coverage for Evzio. C. On January 10, 2018, Relator filed an actio
SETTLEMENT AGREEMENTSettlement Agreement • November 5th, 2021
Contract Type FiledNovember 5th, 2021This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice (the “United States”); kaléo, Inc. (“kaléo” or “Kaléo”); and Rebecca Socol (the “Relator”), through their authorized representatives (together, the “Parties”).
SETTLEMENT AGREEMENTSettlement Agreement • November 5th, 2021
Contract Type FiledNovember 5th, 2021This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice (the “United States”); kaléo, Inc. (“kaléo” or “Kaléo”); and Rebecca Socol (the “Relator”), through their authorized representatives (together, the “Parties”).